Analysts Set Cardinal Health, Inc. (NYSE:CAH) PT at $103.07

Shares of Cardinal Health, Inc. (NYSE:CAH) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $103.07.

Several brokerages have recently commented on CAH. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. Barclays initiated coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price objective for the company. UBS Group boosted their target price on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a report on Monday, February 5th. SVB Leerink began coverage on Cardinal Health in a report on Monday, February 26th. They set an “outperform” rating and a $125.00 price target for the company. Finally, StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors have recently made changes to their positions in the stock. Clearstead Trust LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth about $25,000. Raleigh Capital Management Inc. increased its stake in Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after purchasing an additional 268 shares in the last quarter. Cornerstone Planning Group LLC bought a new position in shares of Cardinal Health during the 3rd quarter worth approximately $26,000. BKM Wealth Management LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $30,000. Finally, Hexagon Capital Partners LLC lifted its position in shares of Cardinal Health by 53.6% in the fourth quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock worth $34,000 after purchasing an additional 118 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE CAH opened at $103.54 on Monday. Cardinal Health has a twelve month low of $77.56 and a twelve month high of $116.04. The stock has a market cap of $25.18 billion, a PE ratio of 40.76, a PEG ratio of 0.99 and a beta of 0.68. The firm has a 50-day simple moving average of $109.56 and a 200 day simple moving average of $104.59.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.26. The business had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.32 EPS. Research analysts forecast that Cardinal Health will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.93%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is 78.74%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.